Whitepapers/App Notes/Posters

Application note: Rapid Analysis of Genotoxic Nitrosamines by HPLC-MS/MS

Posted: 16 July 2019 | | No comments yet

Genotoxic impurities (GTI’s) are intermediate, reactive products or degradants formed during drug synthesis, formulation or storage.

These impurities can damage human genetic material at very low levels, leading to DNA mutations which can contribute to tumorigenesis and carcinogenicity. Because of these compounds’ potencies, they pose a threat to the safety of medication. To prevent large-scale recall incidents, such as those involving nelfinavir mesylate (Viracept) in 2007, or valsartan (Diovan) in 2018, regulatory agencies including the US FDA and the European Medicines Agency (EMA), have issued guidelines on the allowable limits of genotoxic impurities in pharmaceutical products to ensure their safety. These guidelines state exposure to GTI’s must be below the threshold of toxicological concern (TTC) of 1.5 µg per day.











To read this Application note in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsors: SCIEX

Send this to a friend